sar425899 sanofi glp-1 glucagon dual agonist Gut hormone polyagonists for the treatment of type 2 diabetes Multiagonists Currently in Development. |
Description
One thing to keep in mind is that for this medication, the side effects dont fade
4a and b)
Giugliano D, Longo M, Scappaticcio L, et al
doi: 10.1002/jcph.1638, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 133
This type of hypoglycemia was clearly hyperinsulinemic, yet the signal for insulin secretion was unknown
7 As the benefits of the GLP-1 receptor agonists with T2D, obesity, and cardiovascular health are becoming widely known, research into using these agents to treat other conditions has accelerated
